Status: current, Defined. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3738599016 | Product containing only bevacizumab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3738600018 | Bevacizumab only product in parenteral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Bevacizumab only product in parenteral dose form | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Some | ||
| Bevacizumab only product in parenteral dose form | Is a | Bevacizumab only product | true | Inferred relationship | Some | ||
| Bevacizumab only product in parenteral dose form | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Bevacizumab only product in parenteral dose form | Is a | Bevacizumab-containing product in parenteral dose form | true | Inferred relationship | Some | ||
| Bevacizumab only product in parenteral dose form | Has active ingredient | Bevacizumab | true | Inferred relationship | Some | 1 | |
| Bevacizumab only product in parenteral dose form | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Bevacizumab 25 mg/mL solution for injection | Is a | True | Bevacizumab only product in parenteral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR